Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Endocr Res ; 38(4): 232-41, 2013.
Article in English | MEDLINE | ID: mdl-23496416

ABSTRACT

BACKGROUND: Endocrine disrupters have been shown to affect the male and female reproductive systems and to alter potential fertility. OBJECTIVES: This study was conducted to evaluate the effect of a continuous-release pellet containing 12 mg of zeranol for 30 days on the testes and the prostate gland of mature male rats. RESULTS: Zeranol treatment induced significant decrease of the testes and the prostate gland weights which were associated with a remarkable atrophy of the testicular seminiferous tubules and prominent regression of the glandular compartment of the prostate gland. However, zeranol treatment increased the thickness of the periductal layer of stromal cells of the prostate gland from a thin layer that express intense immunostaining of SM-actin and mild vimentin to a thicker layer of cells that exhibited intense immunostaining for both SM-actin and vimentin. CONCLUSION: These findings suggest that zeranol-induced changes to the prostate gland could result from either a direct effect of zeranol on the prostate gland or an indirect effect by interfering with testosterone production through disruption of testicular function.


Subject(s)
Estrogens, Non-Steroidal/adverse effects , Prostate/drug effects , Testis/drug effects , Zeranol/adverse effects , Actins/analysis , Animals , Atrophy , Male , Organ Size/drug effects , Prostate/chemistry , Prostate/pathology , Rats , Rats, Inbred ACI , Testis/pathology , Testosterone/biosynthesis , Vimentin/analysis
2.
Life Sci ; 91(5-6): 194-8, 2012 Sep 04.
Article in English | MEDLINE | ID: mdl-22820544

ABSTRACT

AIMS: The aim of this study was to investigate the effect of testosterone treatment on the proliferation index and the mRNA expression levels of 5α-reductase, CYP7B1, androgen receptor (AR), and estrogen receptor ß (ΕRß) in the canine prostate. MAIN METHODS: Immature dogs were treated with testosterone for one month, after which prostate gland growth was assessed by comparing the proliferation index in prostates from testosterone-treated dogs with that of untreated control dogs. The relative mRNA expression levels of the aforementioned genes in the prostate glands of testosterone-treated and untreated dogs were determined by real time PCR. KEY FINDINGS: Testosterone treatment induced a highly significant reduction in proliferation index in prostate gland. This inhibition of prostate gland growth was associated with differential mRNA expression of 5α-reductase, CYP7B1, AR, and ΕRß by the prostate gland of testosterone-treated dogs, as compared to that of untreated dogs. While the expression levels of 5α-reductase and CYP7B1 mRNA were significantly down-regulated by testosterone treatment, the expression level of ER-ß mRNA was highly up-regulated. In contrast, AR mRNA expression was not significantly altered. SIGNIFICANCE: Prostate gland proliferation appeared to be associated with the expression levels of genes that encode proteins that control intra-prostatic levels of testosterone metabolites and their respective receptors. Testosterone treatment may regulate gene expression in the prostate to generate a phenotype that suppresses growth-promoting signaling through AR and enhances anti-proliferative signaling through ERß. Therefore, targeting disturbances of this genetic machinery in benign prostate hyperplasia and prostate cancer is of a therapeutic potential.


Subject(s)
Androgens/pharmacology , Down-Regulation/drug effects , Prostate/drug effects , Testosterone/analogs & derivatives , Up-Regulation/drug effects , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Androgens/metabolism , Animals , Cell Proliferation/drug effects , Dogs , Estrogen Receptor beta/genetics , Male , Polymerase Chain Reaction , Prostate/metabolism , RNA, Messenger/metabolism , Receptors, Androgen/genetics , Signal Transduction/drug effects , Steroid Hydroxylases/genetics , Testosterone/metabolism , Testosterone/pharmacology
3.
Endocrine ; 31(1): 38-43, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17709896

ABSTRACT

Testosterone regulation of prostate gland growth has been shown to involve reciprocal interaction with inhibin and activin. This study was therefore conducted to correlate the effect of testosterone on prostate gland proliferation and differentiation with the level of expression of inhibin alpha and betaA subunits. Immature dogs were treated with testosterone for 0, 3, 7, and 14 days and prostate gland growth was assessed by morphological and immunohistological localization of differentiation and proliferation markers. The results showed that testosterone treatment resulted in an initial significant increase in PCNA proliferation index by days 3 and 7, followed by a significant decrease by day 14 post-treatment. Interestingly, the decrease of cell proliferation was associated with structural and biochemical changes characteristic of glandular and stromal differentiation of the prostate gland. These changes include progressive glandular ductal canalization and inter-ductal stroma differentiation which were apparent from a gradual shift from vimentin expression to vimentin and alpha-actin expression. Testosterone also had a differential effect on inhibin alpha and beta subunits. Although testosterone treatment resulted in significant and constant inhibition of alpha subunit mRNA expression, it resulted in a significant increase of betaA mRNA expression by day 3, followed by a decrease by days 7 and 14. These results indicated that testosterone acts first to drive proliferation of undifferentiated prostatic cells and then to maintain a low proliferation turnover of differentiated cells. Because it has been shown that activin is an antagonistic regulator of androgens, the attenuated stimulatory effect of testosterone on cell proliferation by day 14 might be mediated, at least in part, by interplay between testosterone and activin.


Subject(s)
Cell Differentiation/physiology , Inhibin-beta Subunits/metabolism , Inhibins/metabolism , Prostate/growth & development , Testosterone/physiology , Animals , Cell Proliferation , Dogs , Male , Prostate/cytology , Prostate/metabolism , RNA, Messenger/metabolism
4.
Endocr J ; 54(4): 521-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17527004

ABSTRACT

This study was conducted to evaluate the long term effect of castration on the prostate gland proliferation, extracellular matrix remodeling and angiogenesis. Prostate gland proliferation was assessed by immunolocalization of proliferating cell nuclear antigen (PCNA). The expression level of vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-beta) and metaloprotenase-13 (MMP-13) by the prostate gland were assessed by immunohistochemistry and quantitative real-time PCR. The expression of the above mentioned parameters by the prostate gland of mature intact dogs were compared to that of castrated dogs six months post-castration. The results showed that castration induced a remarkable atrophy of the prostate gland which was associated with a highly significant decrease in the PCNA proliferation index. Although TGF-beta protein was immunolocalized to the epithelial and stroma cells of the prostate gland from both intact and castrated dogs, castration induced a significant up-regulation of TGF-beta mRNA expression. VEGF mRNA expression and its encoded protein immunolocalization were decreased significantly by the prostate gland from castrated dogs as compared to that of intact dogs. Castration, on the other hand, resulted in no significant change in MMP-13 mRNA expression despite an effect on its cellular immunolocalization which appeared to be localized to the epithelial and stromal cells of the prostate gland from castrated dogs as compared to epithelial cells of the prostate gland from intact dogs. These results indicated that castration-induced prostate gland regression continued to exert a potent suppressive effect on prostate gland proliferation which might be mediated by the elevated level of TGF-beta. Moreover, the low expression level of VEGF might reflect a reduced blood flow demand by the regressed and growth-dormant prostate after castration.


Subject(s)
Extracellular Matrix/physiology , Neovascularization, Physiologic/physiology , Orchiectomy , Prostate/blood supply , Prostate/pathology , Animals , Atrophy , Cell Division/physiology , Dogs , Epithelial Cells/pathology , Gene Expression/physiology , Male , Matrix Metalloproteinase 13/genetics , Prostate/physiology , Stromal Cells/pathology , Transforming Growth Factor beta/genetics , Vascular Endothelial Growth Factor A/genetics
5.
Life Sci ; 80(9): 829-34, 2007 Feb 06.
Article in English | MEDLINE | ID: mdl-17157324

ABSTRACT

The aim of this study was to evaluate the effect of testosterone treatment on the pattern of prostate cell proliferation and differentiation and their correlation with the expression of transforming growth factor-beta (TGF-beta). Prostate gland development was compared in intact immature dogs with one-month testosterone-treated immature dogs. Testosterone treatment resulted in a tenfold increase in prostate gland weight compared to untreated dogs, with a typical organization of the gland into a structure similar to that observed in mature dogs. The narrow acini which contain flat basal cells in immature glands were transformed into tubuloacinar structures containing columnar secretory cells and basal cells. The stromal compartments showed an increase in the muscular component as evidenced by the high reactivity to alpha-actin with no remarkable changes in the vimentin expression. In addition, testosterone treatment induced a significant reduction in the proliferation capacity of stromal cells but with no noticeable changes in the proliferation pattern of epithelial cells. These changes in the prostate are associated with a twofold decrease in TGF-beta mRNA expression as assessed by Real-Time PCR. However, the immunolocalization of TGF-beta was shifted slightly from the epithelial cells in untreated animals to the stromal cells of treated animals. Based on these results it appears that testosterone acts to coordinate prostatic cell proliferation and differentiation and direct their organization into a structure resembling that of the mature gland. The testosterone regulation of the prostate gland appears to involve the regulation of TGF-beta gene expression.


Subject(s)
Androgens/pharmacology , Prostate , Testosterone/pharmacology , Transforming Growth Factor beta/metabolism , Animals , Dogs , Immunohistochemistry , Male , Organ Size/drug effects , Prostate/drug effects , Prostate/growth & development , Prostate/metabolism
6.
Life Sci ; 77(22): 2752-9, 2005 Oct 14.
Article in English | MEDLINE | ID: mdl-15978633

ABSTRACT

This study was conducted to evaluate the effect of androgen ablation on dog prostate gland structure and the proliferation capacity of the prostatic cells and their association with the expression of Activin A and Activin RIIA receptor. The effect of androgen on the prostate gland was compared in intact and castrated dogs after one and two weeks. Specific primary antibodies were used to immunolocalize activin-A, activin receptor type II A and the proliferation marker (PCNA). The results showed that the glandular acini of the prostate gland of intact dogs are lined by tall columnar secretory cells and less abundant flattened basal cells and surrounded by a thin fibromuscular tissue. The cytoplasm of the glandular cells exhibited an intense immunoreaction for activin A and activin RIIA receptor while basal cells expressed PCNA. Castration induced a remarkable atrophy of the prostatic acini associated with a progressive loss of secretory epithelial cells, which showed a dramatic decrease to complete disappearance of Activin A and Activin RIIA receptor immunoreactions. The remaining cells of the atrophied acini continue to express PCNA and the inter-acinar fibromuscular tissue showed a remarkable increase in its mass and are induced to express PCNA. These results indicated that androgen is required for the survival of epithelial cells and to maintain growth-quiescent fibromuscular cells, while basal cell proliferation is androgen independent. The changes in the Activin A and Activin RIIA receptor localization and their association with the dynamic pattern of prostate gland regression after castration suggested that Activin A and Activin RIIA receptor expression are androgen dependent.


Subject(s)
Activin Receptors, Type II/metabolism , Activins/metabolism , Dogs , Gene Expression Regulation , Inhibin-beta Subunits/metabolism , Orchiectomy/veterinary , Prostate/metabolism , Androgens/metabolism , Animals , Cytoplasm/metabolism , Immunohistochemistry/veterinary , Male , Proliferating Cell Nuclear Antigen , Prostate/cytology
7.
Endocr Res ; 30(3): 327-34, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15554348

ABSTRACT

This study was conducted to gain further insight into the role of androgen in maintaining a balanced prostate gland growth in dogs. Effects of castration on prostatic cell were assessed by comparing the expression level of high molecular weight cytokeratin (HMW), alpha-actin, and vimentin in intact and castrated dogs. Mature dogs were castrated while they were under general anesthesia and were killed after 1 month. Mature prostate gland structures from intact dogs are characterized by the presence of differentiated columnar secretary epithelial cells and progenitor basal cells that are located within acini and ducts embedded in a thin fibromuscular tissue. Basal cells were distinguished from secretory epithelial cells by HMW cytokeratin immunostaining, which is expressed specifically by basal cells but not by epithelial cells. Castration-induced secretory epithelial cell death, leave the basal cells intact to form a continuous layer lining the atrophied acini. However, the survived basal cells lost their capacity to differentiate to secretory epithelial cells. In addition, androgen ablation induced remarkable reorganization of the cellular components of the fibromuscular compartment. In intact dogs, this compartment of prostate gland is composed mainly of differentiated smooth muscles and scattered mesenchymal muscles as reflected by the high and low actin and vimentin expressions, respectively. Castration for 1 month induced a progressive shift toward mesenchymal cells, which appeared to occupy most of the fibromuscular compartment. Based on these findings, it appears that androgen acts to maintain a steady state of prostate gland by driving the differentiation of prostatic cells and by maintaining its fully differentiated state.


Subject(s)
Actins/metabolism , Androgens/physiology , Cell Differentiation/physiology , Keratins/metabolism , Prostate/cytology , Prostate/metabolism , Vimentin/metabolism , Androgens/deficiency , Animals , Castration , Dogs , Epithelial Cells/cytology , Epithelial Cells/metabolism , Male , Muscle Cells/cytology , Muscle Cells/metabolism , Prostate/growth & development , Random Allocation , Stem Cells/cytology , Stem Cells/metabolism , Testis/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...